SEC 13F Intelligence

Rhenman & Partners Asset Management AB / BSX

Rhenman & Partners Asset Management AB’s Boston Scientific Corp Position

Does Rhenman & Partners Asset Management AB own Boston Scientific Corp (BSX)? Yes — 625.0K shares worth $39M (+4.84% of its 13F portfolio) as of Q1 2026, up from 431.2K shares the prior filed quarter.

Position Value
$39M
Q1 2026
Shares
625.0K
% of Portfolio
+4.84%
Quarters Held
30
currently held

Position History BSX

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $14MQ2 ’19: $17MQ3 ’19: $15MQ4 ’19: $20MQ4 ’19Q1 ’20: $18MQ2 ’20: $14MQ3 ’20: $17MQ4 ’20: $19MQ4 ’20Q1 ’21: $26MQ2 ’21: $22MQ3 ’21: $25MQ4 ’21: $39MQ4 ’21Q1 ’22: $23MQ2 ’22: $27MQ3 ’22: $30MQ4 ’22: $27MQ4 ’22Q1 ’23: $30MQ2 ’23: $31MQ3 ’23: $37MQ4 ’23: $43MQ4 ’23Q1 ’24: $40MQ2 ’24: $46MQ3 ’24: $49MQ4 ’24: $40MQ4 ’24Q1 ’25: $30MQ2 ’25: $32MQ3 ’25: $43MQ4 ’25: $41MQ4 ’25Q1 ’26: $39Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026625.0K$39M+4.84%
Q4 2025431.2K$41M+3.84%
Q3 2025438.0K$43M+4.73%
Q2 2025296.0K$32M+4.02%
Q1 2025300.0K$30M+3.48%
Q4 2024444.0K$40M+4.08%
Q3 2024590.0K$49M+4.01%
Q2 2024595.0K$46M+4.40%
Q1 2024582.0K$40M+3.78%
Q4 2023750.0K$43M+4.33%
Q3 2023700.0K$37M+3.98%
Q2 2023580.0K$31M+3.31%
Q1 2023600.0K$30M+3.27%
Q4 2022585.0K$27M+2.82%
Q3 2022695.0K$30M+3.14%
Q2 2022725.0K$27M+3.07%
Q1 2022510.0K$23M+2.23%
Q4 2021910.0K$39M+2.60%
Q3 2021570.0K$25M+1.74%
Q2 2021520.0K$22M+1.51%
Q1 2021670.0K$26M+1.81%
Q4 2020530.0K$19M+1.55%
Q3 2020450.0K$17M+1.53%
Q2 2020410.0K$14M+1.56%
Q1 2020565.0K$18M+2.58%
Q4 2019451.7K$20M+2.24%
Q3 2019370.0K$15M+1.89%
Q2 2019387.9K$17M+1.84%
Q1 2019367.9K$14M+1.65%
Q4 2018377.9K$13M+1.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of BSX.